Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Primary Care Today

Challenges and Solutions to Alzheimer's Research Funding Barriers

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Alzheimer’s Disease is the most common cause of dementia among people aged 65 and older. With the population of older Americans growing, research for new therapies becomes ever more critical. Yet one of the most important factors in advancing research, fundraising, has been hampered by numerous challenges.

    Host Dr. Brian McDonough talks with Charles Fushcillo Jr., President and Chief Executive Officer of the Alzheimer’s Foundation of America about the challenges in securing additional funding for Alzheimer’s Research.

Recommended
Details
Presenters
Comments
  • Overview

    Alzheimer’s Disease is the most common cause of dementia among people aged 65 and older. With the population of older Americans growing, research for new therapies becomes ever more critical. Yet one of the most important factors in advancing research, fundraising, has been hampered by numerous challenges.

    Host Dr. Brian McDonough talks with Charles Fushcillo Jr., President and Chief Executive Officer of the Alzheimer’s Foundation of America about the challenges in securing additional funding for Alzheimer’s Research.

Schedule12 Dec 2024